1. Emerging epigenetic targets in rheumatoid arthritis
   Reema R. Barik et al, 2021, Rheumatology International CrossRef
2. Valproic Acid and Breast Cancer: State of the Art in 2021
   Anna Wawruszak et al, 2021, Cancers CrossRef
3. Singlet Anticancer Therapy Through Epi-Weapons Histone Deacetylase Inhibitors and Its Shortcomings
   Shabir Ahmad Ganai, 2020, Histone Deacetylase Inhibitors in Combinatorial Anticancer Therapy CrossRef
4. HDAC inhibition in cancer
   Appu Rathinavelu et al, 2023, Epigenetics in Organ Specific Disorders CrossRef
5. N-(2-Hydroxyphenyl)-2-Propylpentanamide (HO-AAVPA) Induces Apoptosis and Cell Cycle Arrest in Breast Cancer Cells, Decreasing GPER Expression
   Berenice Prestegui Martel et al, 2024, Molecules CrossRef
6. Recent update on anti-tumor mechanisms of valproic acid in glioblastoma multiforme
   Abulfazl Vatankhah et al, 2024, Pathology - Research and Practice CrossRef
7. Extremely low-frequency electromagnetic field induces acetylation of heat shock proteins and enhances protein folding
   Zhizhou Huang et al, 2023, Ecotoxicology and Environmental Safety CrossRef
8. Evaluation of cell death pathways initiated by antitumor drugs melatonin and valproic acid in bladder cancer cells
   Siwei Liu et al, 2017, FEBS Open Bio CrossRef
9. A three layered histone epigenetics in breast cancer metastasis
   Debparna Nandy et al, 2020, Cell & Bioscience CrossRef
10. Valproic Acid and Lithium Meditate Anti‐Inflammatory Effects by Differentially Modulating Dendritic Cell Differentiation and Function
    Sy‐Jye Leu et al, 2017, Journal of Cellular Physiology CrossRef
11. Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer
    Sumin Oh et al, 2017, Translational Research in Breast Cancer CrossRef
12. Regulation of valproic acid induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple negative breast cancer
    Zeynep Ozman et al, 2021, Molecular Biology Reports CrossRef
13. The Pivotal Immunomodulatory and Anti-Inflammatory Effect of Histone-Lysine N-Methyltransferase in the Glioma Microenvironment: Its Biomarker and Therapy Potentials
    Seidu A. Richard et al, 2021, Analytical Cellular Pathology CrossRef
14. Valproic acid exhibits different cell growth arrest effect in three HPV-positive/negative cervical cancer cells and possibly via inducing Notch1 cleavage and E6 downregulation
    SHUYU FENG et al, 2016, International Journal of Oncology CrossRef
15. Epigenetics in cancer stem cells
    Tan Boon Toh et al, 2017, Molecular Cancer CrossRef
16. Histone deacetylase inhibitors (HDACi) increase expression of KCa2.3 (SK3) in primary microvascular endothelial cells
    Aaron Kolski-Andreaco et al, 2022, American Journal of Physiology-Cell Physiology CrossRef
17. Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)
    Nan Jiang et al, 2018, Experimental and Therapeutic Medicine CrossRef
18. Valproic acid-induced amphiregulin secretion confers resistance to temozolomide treatment in human glioma cells
    Jui-Chieh Chen et al, 2019, BMC Cancer CrossRef
19. [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells
    Laurence Booth et al, 2017, Cancer Biology & Therapy CrossRef
20. Enhanced antitumor activity of combined methotrexate and histone deacetylase inhibitor valproic acid on mammary cancer in vitro and in vivo
    Hadia H. El Said et al, 2022, Canadian Journal of Physiology and Pharmacology CrossRef
21. The role of post-translational modifications in hearing and deafness
    Susana Mateo Sánchez et al, 2016, Cellular and Molecular Life Sciences CrossRef
22. Sodium valproate affects the expression of p16INK4a and p21WAFI/Cip1 cyclin‑dependent kinase inhibitors in HeLa cells
    Marina Rocha et al, 2024, Oncology Letters CrossRef
23. Valproic acid inhibits the protective effects of stromal cells against chemotherapy in breast cancer: Insights from proteomics and systems biology
    Farnaz Barneh et al, 2018, Journal of Cellular Biochemistry CrossRef
24. The HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo
    Laurence Booth et al, 2017, Oncotarget CrossRef
25. Unconventional protein post-translational modifications: the helmsmen in breast cancer
    Jiena Liu et al, 2022, Cell & Bioscience CrossRef
26. The role of protein acetylation in carcinogenesis and targeted drug discovery
    Jingru Yang et al, 2022, Frontiers in Endocrinology CrossRef
27. Untargeted LC-MS/MS Metabolomics Study of HO-AAVPA and VPA on Breast Cancer Cell Lines
    Alan Rubén Estrada-Pérez et al, 2023, International Journal of Molecular Sciences CrossRef
28. Anti-proliferative and Apoptotic Effects of Valproic Acid on HeLa Cells
    Nasser Hashemi et al, 2022, International Journal of Cancer Management CrossRef
29. HDAC inhibitors enhance the immunotherapy response of melanoma cells
    Laurence Booth et al, 2017, Oncotarget CrossRef
30. Evaluation of Cytotoxic Activity of Epigenetic Drugs in Oesophageal Squamous Cell Carcinoma
    Róisín M. Cassidy et al, 2023, European Journal of Medical and Health Sciences CrossRef
31. BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma
    Ben Davidson et al, 2016, Human Pathology CrossRef
32. Epigenetic regulation of breast cancer metastasis
    Chitra Thakur et al, 2024, Cancer and Metastasis Reviews CrossRef
33. Recent advancement of HDAC inhibitors against breast cancer
    Syed Abdulla Mehmood et al, 2023, Medical Oncology CrossRef
34. Deacetylation of HSC70-4 Promotes Bombyx mori Nucleopolyhedrovirus Proliferation via Proteasome-Mediated Nuclear Import
    Fuxiang Mao et al, 2021, Frontiers in Physiology CrossRef
35. Heat Shock Proteins and Breast Cancer
    Miao Zhang et al, 2024, International Journal of Molecular Sciences CrossRef
36. The Effect of VPA on Increasing Radiosensitivity in Osteosarcoma Cells and Primary-Culture Cells from Chemical Carcinogen-Induced Breast Cancer in Rats
    Guochao Liu et al, 2017, International Journal of Molecular Sciences CrossRef
37. The Histone Acetylation Modifications of Breast Cancer and their Therapeutic Implications
    Pingping Guo et al, 2018, Pathology & Oncology Research CrossRef
38. The Effect of Berberine Follow by Blue Light Irradiation and Valproic Acid on the Growth Inhibition of MDA-MB-231 Breast Cancer Cells
    Mahdieh Meschi et al, 2023, Applied Biochemistry and Biotechnology CrossRef
39. Emerging role of histone deacetylase inhibitors as anti-breast-cancer agents
    Meran Keshawa Ediriweera et al, 2019, Drug Discovery Today CrossRef
40. Valproic Acid: A Promising Therapeutic Agent in Glioma Treatment
    Wei Han et al, 2021, Frontiers in Oncology CrossRef
41. Histone deacetylase inhibitors VPA and WT161 ameliorate the pathological features and cognitive impairments of the APP/PS1 Alzheimer’s disease mouse model by regulating the expression of APP secretases
    Miaomiao Zhang et al, 2024, Alzheimer's Research & Therapy CrossRef
42. Hormonal and Genetic Regulatory Events in Breast Cancer and Its Therapeutics: Importance of the Steroidogenic Acute Regulatory Protein
    Pulak R. Manna et al, 2022, Biomedicines CrossRef
43. ARD1 contributes to IKKβ-mediated breast cancer tumorigenesis
    Yu Zhang et al, 2018, Cell Death & Disease CrossRef
44. VPA and TSA Interrupt the Interplay between mutp53 and HSP70, Leading to CHK1 and RAD51 Down-Regulation and Sensitizing Pancreatic Cancer Cells to AZD2461 PARP Inhibitor
    Maria Anele Romeo et al, 2022, International Journal of Molecular Sciences CrossRef
45. An overview of epigenetic agents and natural nutrition products targeting DNA methyltransferase, histone deacetylases and microRNAs
    Deyu Huang et al, 2019, Food and Chemical Toxicology CrossRef
46. Window-of-Opportunity Study of Valproic Acid in Breast Cancer Testing a Gene Expression Biomarker
    Adam L. Cohen et al, 2017, JCO Precision Oncology CrossRef
47. HSP70s in Breast Cancer: Promoters of Tumorigenesis and Potential Targets/Tools for Therapy
    Alexander E. Kabakov et al, 2021, Cells CrossRef
48. Valproic Acid-Induced CCN1 Promotes Osteogenic Differentiation by Increasing CCN1 Protein Stability through HDAC1 Inhibition in Tonsil-Derived Mesenchymal Stem Cells
    Yeonsil Yu et al, 2022, Cells CrossRef
49. Valproic acid inhibits the angiogenic potential of cervical cancer cells via HIF-1α/VEGF signals
    Y. Zhao et al, 2016, Clinical and Translational Oncology CrossRef
50. Untargeted LC-MS/MS Metabolomics Study on the MCF-7 Cell Line in the Presence of Valproic Acid
    Alan Rubén Estrada-Pérez et al, 2022, International Journal of Molecular Sciences CrossRef
51. Drug Repurposing: The Mechanisms and Signaling Pathways of Anti-Cancer Effects of Anesthetics
    King-Chuen Wu et al, 2022, Biomedicines CrossRef